Search research articles
Contact Us
Filters
Showing results (71-80 of 154) with videos related to
Page
of 16
Sort By:
Biochemical Pharmacology
|
December 13, 2022
Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines
Jing Gao, Chen Zhou, Yan Zhong, et al.
Analytical and Bioanalytical Chemistry
|
February 6, 2010
An enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide as a monomer
Chunyi Jiang, Yu Feng, Xiaotong Huang, et al.
Journal of Medicinal Chemistry
|
October 20, 2015
Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors
Xinde Chen, Wenwei Xu, Kai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2013
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase
Fang Bai, Yechun Xu, Jing Chen, et al.
European Journal of Medicinal Chemistry
|
January 17, 2018
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
Xuxing Chen, Xiajuan Huan, Qiufeng Liu, et al.
European Journal of Medicinal Chemistry
|
December 3, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination
Haiyan Cai, Qiufeng Liu, Dingding Gao, et al.
Angewandte Chemie (International Ed. in English)
|
December 1, 2021
Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
Xiangbo Yang, Huimin Lu, Hang Xie, et al.
Journal of Medicinal Chemistry
|
December 16, 2022
Discovery of 10<i>H</i>-Benzo[<i>b</i>]pyrido[2,3-<i>e</i>][1,4]oxazine AXL Inhibitors <i>via</i> Structure-Based Drug Design Targeting c-Met Kinase
Zhengsheng Zhan, Yinchun Ji, Haixia Su, et al.
Journal of Advanced Research
|
September 24, 2025
Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer
Liang Xiong, Lei Tang 唐磊, Wenfeng Zhao, et al.
Journal of Virology
|
April 27, 2026
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir
Lu Chen, Haixia Su, Weijuan Shang, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 154) with videos related to
Sort By:
Page
of 16
Biochemical Pharmacology
|
December 13, 2022
Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines
Jing Gao, Chen Zhou, Yan Zhong, et al.
Analytical and Bioanalytical Chemistry
|
February 6, 2010
An enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide as a monomer
Chunyi Jiang, Yu Feng, Xiaotong Huang, et al.
Journal of Medicinal Chemistry
|
October 20, 2015
Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors
Xinde Chen, Wenwei Xu, Kai Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2013
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase
Fang Bai, Yechun Xu, Jing Chen, et al.
European Journal of Medicinal Chemistry
|
January 17, 2018
Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors
Xuxing Chen, Xiajuan Huan, Qiufeng Liu, et al.
European Journal of Medicinal Chemistry
|
December 3, 2014
Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination
Haiyan Cai, Qiufeng Liu, Dingding Gao, et al.
Angewandte Chemie (International Ed. in English)
|
December 1, 2021
Potent and Selective RIPK1 Inhibitors Targeting Dual-Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
Xiangbo Yang, Huimin Lu, Hang Xie, et al.
Journal of Medicinal Chemistry
|
December 16, 2022
Discovery of 10<i>H</i>-Benzo[<i>b</i>]pyrido[2,3-<i>e</i>][1,4]oxazine AXL Inhibitors <i>via</i> Structure-Based Drug Design Targeting c-Met Kinase
Zhengsheng Zhan, Yinchun Ji, Haixia Su, et al.
Journal of Advanced Research
|
September 24, 2025
Orthosteric-allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer
Liang Xiong, Lei Tang 唐磊, Wenfeng Zhao, et al.
Journal of Virology
|
April 27, 2026
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir
Lu Chen, Haixia Su, Weijuan Shang, et al.
Page
of 16